Peregrine Capital Management LLC Has $5.25 Million Stock Holdings in Cabot Corporation $CBT

Key Points

• Peregrine Capital Management LLC increased its stake in Cabot by 24.7% to 79,148 shares worth about $5.25 million, roughly 0.15% of the company.
• Cabot beat quarterly EPS expectations ($1.53 vs. $1.40) but missed revenue ($849M vs. $889.1M) with revenue down 11.1% year‑over‑year, and set FY2026 EPS guidance of $6.00–$6.50 (analyst average ~$6.27).
• Analysts have a consensus "Hold" rating with a $73.75 price target (1 Buy, 4 Hold, 1 Sell), and institutional ownership is high at ~93.18%.

Peregrine Capital Management LLC lifted its stake in Cabot Corporation (NYSE:CBT - Free Report) by 24.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 79,148 shares of the specialty chemicals company's stock after acquiring an additional 15,669 shares during the quarter. Peregrine Capital Management LLC owned approximately 0.15% of Cabot worth $5,246,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the stock. M&T Bank Corp increased its stake in shares of Cabot by 57.0% in the fourth quarter. M&T Bank Corp now owns 25,764 shares of the specialty chemicals company's stock worth $1,708,000 after acquiring an additional 9,351 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Cabot by 3.8% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,780 shares of the specialty chemicals company's stock worth $1,046,000 after acquiring an additional 575 shares during the last quarter. Bayforest Capital Ltd increased its position in Cabot by 461.1% during the fourth quarter. Bayforest Capital Ltd now owns 3,372 shares of the specialty chemicals company's stock worth $223,000 after buying an additional 2,771 shares during the last quarter. Farther Finance Advisors LLC increased its position in Cabot by 9.6% during the fourth quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company's stock worth $124,000 after buying an additional 164 shares during the last quarter. Finally, Harbor Capital Advisors Inc. increased its position in Cabot by 16.9% during the fourth quarter. Harbor Capital Advisors Inc. now owns 25,890 shares of the specialty chemicals company's stock worth $1,716,000 after buying an additional 3,737 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have commented on CBT. Jefferies Financial Group reissued a "buy" rating and set a $85.00 target price on shares of Cabot in a research report on Wednesday, February 4th. Zacks Research raised shares of Cabot from a "strong sell" rating to a "hold" rating in a research report on Tuesday, January 27th. UBS Group increased their target price on shares of Cabot from $74.00 to $81.00 and gave the stock a "neutral" rating in a research report on Thursday, February 5th. Mizuho set a $75.00 target price on shares of Cabot and gave the stock a "neutral" rating in a research report on Wednesday, February 4th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Cabot in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $73.75.

Cabot Trading Up 1.1%

Cabot stock opened at $76.27 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09. The company has a market capitalization of $3.98 billion, a price-to-earnings ratio of 13.36, a PEG ratio of 9.94 and a beta of 0.84. Cabot Corporation has a one year low of $58.33 and a one year high of $83.71. The company's fifty day moving average price is $73.48 and its two-hundred day moving average price is $70.02.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.13. The company had revenue of $849.00 million for the quarter, compared to the consensus estimate of $889.11 million. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The firm's revenue was down 11.1% compared to the same quarter last year. During the same period last year, the business posted $1.76 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. On average, analysts forecast that Cabot Corporation will post 6.27 earnings per share for the current fiscal year.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.